Related Experiment Video
Updated: Jul 9, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Treating cardiovascular disease in women
1East Sussex NHS Trust, Eastbourne District General Hospital, Eastbourne, East Sussex, UK.
Insights
Cardiovascular disease (CVD) management in women presents unique challenges, often diagnosed later with more co-morbidities. Addressing modifiable risk factors is key for effective treatment and prevention in female patients.
Area of Science:
- Cardiology
- Women's Health
- Preventive Medicine
Background:
- Cardiovascular disease (CVD) is a leading cause of mortality in women, with distinct management challenges compared to men.
- Women often present with ischaemic heart disease at an older age and with more co-morbidities like diabetes and hypertension.
Purpose of the Study:
- To address gender-specific issues in cardiovascular management for women.
- To emphasize the modification of coronary risk factors in the context of ischaemic heart disease in women.
Main Methods:
- Review of gender-specific challenges in CVD management.
- Analysis of modifiable and non-modifiable risk factors in women.
- Discussion of treatment modalities including pharmacotherapy, percutaneous intervention, and surgical revascularization.
Main Results:
- Women with ischaemic heart disease present later, are older, and have higher rates of co-morbidities.
- Modifiable risk factors include diabetes, dyslipidaemia, hypertension, smoking, obesity, sedentary lifestyle, and poor nutrition.
- Age and general health significantly influence treatment response variability.
Conclusions:
- Effective cardiovascular disease management in women requires consideration of age and co-morbidities.
- Targeting modifiable risk factors is crucial for improving outcomes.
- Comprehensive strategies including pharmacotherapy, interventions, and cardiac rehabilitation are essential for women's cardiovascular health.
Abstract:
Cardiovascular disease (CVD) is the most common cause of death in women but some of the challenges of management differ from those in men. This article addresses the gender-specific issues of cardiovascular management, with emphasis on ischaemic heart disease and modification of coronary risk factors. Women with ischaemic heart disease present later than men, and are therefore older and more likely to suffer from co-morbidities such as diabetes and hypertension. Proven CVD risk factors in women can be divided into those that are modifiable and those that are non-modifiable. The former include diabetes, dyslipidaemia, hypertension, smoking, obesity, sedentary lifestyle and poor nutrition; the latter include family history of heart disease and older age at presentation. It is this difference in age and general health that explains much of the variability in response to treatment. Pharmacotherapy, percutaneous intervention, surgical revascularization, and cardiac rehabilitation and disease prevention are discussed.
Related Concept Videos
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease V: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Cardiovascular Drugs: Classification based on Therapeutic Indications
Angina IV: Management